These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

501 related items for PubMed ID: 18588560

  • 1. A 12-week placebo-controlled study of rupatadine 10 mg once daily compared with cetirizine 10 mg once daily, in the treatment of persistent allergic rhinitis.
    Fantin S, Maspero J, Bisbal C, Agache I, Donado E, Borja J, Mola O, Izquierdo I, international Rupatadine study group.
    Allergy; 2008 Jul; 63(7):924-31. PubMed ID: 18588560
    [Abstract] [Full Text] [Related]

  • 2. Rupatadine 10 mg and ebastine 10 mg in seasonal allergic rhinitis: a comparison study.
    Guadaño EM, Serra-Batlles J, Meseguer J, Castillo JA, De Molina M, Valero A, Picado C, Rupatadine Study Group.
    Allergy; 2004 Jul; 59(7):766-71. PubMed ID: 15180765
    [Abstract] [Full Text] [Related]

  • 3. Effectiveness of azelastine nasal spray compared with oral cetirizine in patients with seasonal allergic rhinitis.
    Corren J, Storms W, Bernstein J, Berger W, Nayak A, Sacks H, Azelastine Cetirizine Trial No. 1 (ACT 1) Study Group.
    Clin Ther; 2005 May; 27(5):543-53. PubMed ID: 15978303
    [Abstract] [Full Text] [Related]

  • 4. Rupatadine oral solution in children with persistent allergic rhinitis: A randomized, double-blind, placebo-controlled study.
    Potter P, Maspero JF, Vermeulen J, Barkai L, Németh I, Baillieau RA, Garde JM, Giralt J, Doménech A, Izquierdo I, Nieto A.
    Pediatr Allergy Immunol; 2013 Mar; 24(2):144-50. PubMed ID: 23384091
    [Abstract] [Full Text] [Related]

  • 5. Reduction of nasal volume after allergen-induced rhinitis in patients treated with rupatadine: a randomized, cross-over, double-blind, placebo-controlled study.
    Valero A, Serrano C, Bartrá J, Izquierdo I, Muñoz-Cano R, Mullol J, Picado C.
    J Investig Allergol Clin Immunol; 2009 Mar; 19(6):488-93. PubMed ID: 20128424
    [Abstract] [Full Text] [Related]

  • 6. Efficacy and safety of bilastine 20 mg compared with cetirizine 10 mg and placebo for the symptomatic treatment of seasonal allergic rhinitis: a randomized, double-blind, parallel-group study.
    Kuna P, Bachert C, Nowacki Z, van Cauwenberge P, Agache I, Fouquert L, Roger A, Sologuren A, Valiente R, Bilastine International Working Group.
    Clin Exp Allergy; 2009 Sep; 39(9):1338-47. PubMed ID: 19438584
    [Abstract] [Full Text] [Related]

  • 7. Rupatadine 10 mg and cetirizine 10 mg in seasonal allergic rhinitis: a randomised, double-blind parallel study.
    Martínez-Cócera C, De Molina M, Martí-Guadaño E, Pola J, Conde J, Borja J, Pérez I, Arnaiz E, Izquierdo I, Spanish Rupatadine Rhinitis Study Group.
    J Investig Allergol Clin Immunol; 2005 Sep; 15(1):22-9. PubMed ID: 15864879
    [Abstract] [Full Text] [Related]

  • 8. The comparison of the efficacy and safety of cetirizine, oxatomide, ketotifen, and a placebo for the treatment of childhood perennial allergic rhinitis.
    Lai DS, Lue KH, Hsieh JC, Lin KL, Lee HS.
    Ann Allergy Asthma Immunol; 2002 Dec; 89(6):589-98. PubMed ID: 12487225
    [Abstract] [Full Text] [Related]

  • 9. Cetirizine, loratadine, or placebo in subjects with seasonal allergic rhinitis: effects after controlled ragweed pollen challenge in an environmental exposure unit.
    Day JH, Briscoe M, Widlitz MD.
    J Allergy Clin Immunol; 1998 May; 101(5):638-45. PubMed ID: 9600501
    [Abstract] [Full Text] [Related]

  • 10. Rupatadine and levocetirizine for seasonal allergic rhinitis: a comparative study of efficacy and safety.
    Maiti R, Rahman J, Jaida J, Allala U, Palani A.
    Arch Otolaryngol Head Neck Surg; 2010 Aug; 136(8):796-800. PubMed ID: 20713756
    [Abstract] [Full Text] [Related]

  • 11. Once-daily rupatadine improves the symptoms of chronic idiopathic urticaria: a randomised, double-blind, placebo-controlled study.
    Dubertret L, Zalupca L, Cristodoulo T, Benea V, Medina I, Fantin S, Lahfa M, Pérez I, Izquierdo I, Arnaiz E.
    Eur J Dermatol; 2007 Aug; 17(3):223-8. PubMed ID: 17478385
    [Abstract] [Full Text] [Related]

  • 12. Comparison of efficacy and safety of cetirizine and ebastine in patients with perennial allergic rhinitis.
    Murris-Espin M, Melac M, Charpentier JC, Didier A.
    Ann Allergy Asthma Immunol; 1998 May; 80(5):399-403. PubMed ID: 9609610
    [Abstract] [Full Text] [Related]

  • 13. Comparative study between fluticasone propionate and cetirizine in the treatment of allergic rhinitis.
    D'Ambrosio FP, Gangemi S, Merendino RA, Arena A, Ricciardi L, Bagnato GF.
    Allergol Immunopathol (Madr); 1998 May; 26(6):277-82. PubMed ID: 9934406
    [Abstract] [Full Text] [Related]

  • 14. Rupatadine in allergic rhinitis and chronic urticaria.
    Mullol J, Bousquet J, Bachert C, Canonica WG, Gimenez-Arnau A, Kowalski ML, Martí-Guadaño E, Maurer M, Picado C, Scadding G, Van Cauwenberge P.
    Allergy; 2008 Apr; 63 Suppl 87():5-28. PubMed ID: 18339040
    [Abstract] [Full Text] [Related]

  • 15. Rupatadine in the treatment of chronic idiopathic urticaria: a double-blind, randomized, placebo-controlled multicentre study.
    Gimenez-Arnau A, Pujol RM, Ianosi S, Kaszuba A, Malbran A, Poop G, Donado E, Perez I, Izquierdo I, Arnaiz E, Rupatadine Urticaria Study Group.
    Allergy; 2007 May; 62(5):539-46. PubMed ID: 17441794
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.